Beruflich Dokumente
Kultur Dokumente
Abstract
Nine healthy middle-aged and 10 elderly volunteers drank fermented milk containing 4 3 1010 live cells of Lactobacillus
casei strain Shirota daily for 3 wk, and their natural killer (NK) activity and other immunological functions were examined. In
the experiments with middle-aged volunteers, NK activity significantly increased (P , 0.01) 3 wk after the start of intake,
individuals. In the experiments with elderly volunteers, NK activity significantly decreased (P , 0.01) in the control group
3 wk after the start of intake; however, the intake of Lactobacillus casei strain Shirota maintained the NK activity.
These results suggest that daily intake of Lactobacillus casei strain Shirota provides a positive effect on NK-cell
activity. J. Nutr. 137: 791S793S, 2007.
Introduction
Lactic acid bacteria are commonly used for the manufacture of
fermented milk products and are known to have excellent nutritional and flavoring effects. Recent studies have revealed that
some strains of lactic acid bacteria have health-promoting effects
through improvement of the intestinal microflora and modulation of the immune system (1,2). Lactobacillus casei strain
Shirota (LcS)3 has been shown to have potent antitumor effects
in rodents (3,4), and immunomodulatory effects of this bacterium also have been well documented in animal models (5). In
humans, an LcS preparation has been shown to prevent the
recurrence of superficial bladder cancer, and a possible effect of
LcS on the immune system has been suggested (6,7). Furthermore, habitual intake of lactic acid bacteria containing LcS has
recently been shown to reduce the risk of bladder cancer, and an
effect on the immune system of healthy people has also been
1
Published as a supplement to The Journal of Nutrition. The articles included in
this supplement are derived from presentations and discussions at the World
Dairy Summit 2003 of the International Dairy Federation (IDF) in a joint
IDF/FAO symposium entitled Effects of Probiotics and Prebiotics on Health
MaintenanceCritical Evaluation of the Evidence, held in Bruges, Belgium. The
articles in this publication were revised in April 2006 to include additional relevant
and timely information, including citations to recent research on the topics
discussed. The guest editors for the supplement publication are Michael de
Vrese and J. Schrezenmeir. Guest Editor disclosure: M. de Vrese and
J. Schrezenmeir have no conflict of interest in terms of finances or current
grants received from the IDF. J. Schrezenmeir is the IDF observer for Codex
Alimentarius without financial interest. The editors have received grants or
compensation for services, such as lectures, from the following companies that
market pro- and prebiotics: Bauer, Danone, Danisco, Ch. Hansen, Merck, Muller
Milch, Morinaga, Nestec, Nutricia, Orafti, Valio, and Yakult.
2
Author disclosure: no relationships to disclose.
3
IFN, interferon; LcS, Lactobacillus casei strain Shirota; NK, natural killer.
* To whom correspondence should be addressed. E-mail: kokumura@med.
Juntendo.ac.jp.
elevated NK cell activity remained for the next 3 wk, and this effect was particularly prominent in the low-NK-activity
Results
Figure 1 Change in NK-cell activity during the study period. Each of the
volunteers drank a bottle of Yakult 400 (d) or unfermented (s) milk daily for 3
wk, and NK-cell activity was measured 5 times against K562 target cells at an E/
T ratio of 20 by the Eu release assay. Data are shown as mean 6 SE for 9
individuals in the experimental group and 8 individuals in the control group. **P
, 0.01, *P , 0.05 as compared with the values before intake.
792S
Supplement
Discussion
In this study, we demonstrated that habitual intake of lactic acid
bacteria containing LcS positively influenced NK-cell activity,
which resulted in the augmentation of NK-cell activity in middleaged sunjects and inhibition of the decrease of NK-cell activity in
elderly individuals. Despite the augmentation of NK-cell activity, the number of NK cells was not significantly changed. Thus,
Figure 3 Changes in NK-cell activity against K562 target cells at an E/T ratio of
20 of elderly subjects 3 wk after the start of intake. Subject drank either Yakult
400 or control unfermented milk; the changes in NK-cell activity in each elderly
subject (s) and mean 6 SE of all individuals (d) are shown.
Experiments with the middle-aged subjects. In the experimental group, NK-cell activity was significantly increased 1 wk
(P 0.0598) and 3 wk (P 0.0050) after the start of intake of
the fermented milk drink, compared with the NK-cell activity
before intake (Fig. 1). The NK-cell activity remained elevated for
the next 3 wk (P 0.0221). Two months after the period of
intake, NK-cell activity was found to have returned to almost the
same level as that before intake. On the other hand, the level of
NK-cell activity in the control group did not change significantly
during the entire experimental period. Moreover, the magnitude
of the increase in NK-cell activity induced by intake of the
fermented milk drink was inversely correlated with the levels of
NK-cell activity before intake (P 0.0163) (Fig. 2). These
findings suggest that the continuous intake of the fermented milk
containing LcS is effective to augment NK-cell activity, particularly prominent in the individuals who have low levels of NKcell activity.
The frequencies and the cell numbers of CD32 CD161
CD561 NK cells, CD41 cells, and CD81 cells were not significantly changed in either group (data not shown), the concentration of serum IFN-a did not change, and IFN-g could not be
detected in serum at all (data not shown).
Literature Cited
1.
2.
3.
4.
5.
6.
Gill HS. Stimulation of the immune system by lactic cultures. Int Dairy
J. 1998;8:53544.
Salminen S, Ouwehand AC, Isolauri E. Clinical applications of probiotic bacteria. Int Dairy J. 1998;8:56372.
Kato I, Endo K, Yokokura T. Effects of oral administration of
Lactobacillus casei on antitumor responses induced by tumor resection
in mice. Int J Immunopharmacol. 1994;16:2936.
Takagi A, Matsuzaki T, Sato M, Nomoto K, Morotomi M, Yokokura T.
Inhibitory effect of oral administrartion of Lactobacillus casei on 3methylcholanthrene-induced carcinogenesis in mice. Med Microbiol
Immunol (Berl). 1999;188:1116.
Matsuzaki T. Immunomodulation by treatment with Lactobacillus casei
strain Shirota. Int J Food Microbiol. 1998;41:13340.
Aso Y, Akaza H, the BLP Study Group. Prophylactic effect of a
Lactobacillus casei preparation on the recurrence of superficial bladder
cancer. Urol Int. 1992;49:1259.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
793S
Acknowledgment
The authors thank Yakult Co. for the supply of the L. casei
strain Shirota fermented milk product, Yakult 400, and the
placebo used for this study.
7.